AT-Patch (ATP-C130/ATP-C70) vs 7600 Ultrasound System (MyLabC25)

AT-Patch prioritizes patient comfort and ease of use with its compact, lightweight, and shower-proof design, requiring no charging during its 14-day monitoring period. The accompanying smartphone app further enhances patient usability by allowing live ECG viewing and symptom recording.

While both are FDA-cleared and leverage AI, the Esaote MyLabu2122C25 offers broader diagnostic imaging capabilities across multiple specialties, including Cardiology, OB/GYN, and Radiology. Its AI-powered functions enhance diagnostic imaging and workflow optimization, providing versatile clinical applications.

Neither AT-Patch nor Esaote MyLabu2122C25 provides publicly available pricing information, both operating on an enterprise sales model. Without specific cost details, a direct comparison of their pricing and value propositions is not possible.

The Esaote MyLabu2122C25 explicitly states HIPAA compliance and includes robust networking features for data management and sharing, which are crucial for integration into complex hospital environments. While AT-Patch's HIPAA compliance is inferred, Tool B's explicit claims and data management capabilities indicate a higher level of enterprise readiness.

AT-Patch demonstrates significant innovation by offering up to 14 days of continuous, high-accuracy, and patient-friendly ECG monitoring in a compact, shower-proof wearable device with integrated AI for arrhythmia detection. This represents a more disruptive advancement in remote cardiac monitoring compared to the AI enhancements in an established ultrasound modality.

Esaote provides explicit details on its support offerings, including remote technical support, probe coverage, and a 3-year warranty. It also offers comprehensive documentation and features for collaborative medicine and educational support through live streaming and remote control. ATsens provides user manuals and a document center, but lacks the detailed support structure mentioned by Esaote.